• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    GE HealthCare management to present at upcoming investor conferences

    BUSINESSWIRE

    GE HealthCare Announces Imaging For OEC 3D C-arm In Pulmonology

    BUSINESSWIRE

    GE HealthCare Hosts 2024 Investor Day on Precision Care Innovation

    BUSINESSWIRE

    Pilot Study Shows Portrait Mobile Monitoring Reduces Alarm Fatigue

    BUSINESSWIRE

    GE HealthCare & RadNet Partner to Accelerate AI in Imaging

    GLOBENEWSWIRE

    GE HealthCare to Host its 2024 Investor Day on November 21

    BUSINESSWIRE

    GE HealthCare Commences Secondary Offering of 13.3M Shares

    BUSINESSWIRE

    GE HealthCare Prices Secondary Offering of 13.3M Shares

    BUSINESSWIRE

    GE HealthCare reports third quarter 2024 financial results

    BUSINESSWIRE

    GE HealthCare Announces AI Innovation Lab With Five Research Projects

    BUSINESSWIRE

    GE HealthCare, Antetokounmpo Family Foundation Commit $1M

    BUSINESSWIRE

    GE HealthCare And University Medicine Essen Advance Theranostics

    BUSINESSWIRE

    GE HealthCare To Announce Third Quarter 2024 Results October 30

    BUSINESSWIRE

    GE HealthCare Announces Phase I Results For MRI Contrast Agent

    BUSINESSWIRE

    US FDA approves GE HealthCare`s diagnostic drug for heart disease

    REUTERS

    GE HealthCare Shows AI-enhanced Radiation Therapy At ASTRO

    BUSINESSWIRE

    GE HealthCare Introduces Elevated Venue Ultrasound Solutions

    BUSINESSWIRE

    GE HealthCare announces cash dividend for third quarter of 2024

    BUSINESSWIRE

    GE HealthCare Gets FDA Clearance For Alzheimer`s Imaging Software

    FIERCE BIOTECH

    Clinical Study Shows Improved Efficiency And Accuracy Of Anesthesia Delivery

    BUSINESSWIRE

    GE Healthcare`s Generics Regadenoson Receives Approval in US

    FDA

    GE HealthCare to announce second quarter 2024 results on July 31, 2024

    BUSINESSWIRE

    GE HealthCare And MediView Install First AR Suite For Interventional Radiology

    BUSINESSWIRE

    GE HealthCare Announces Changes In Strategic Leadership And Key Segments

    BUSINESSWIRE

    GE Healthcare Increasing Personalized Medicine Access Globally

    BUSINESSWIRE

    GE HealthCare: Breast Cancer PET Tracer May Yield Clinical/Economic Benefits

    BUSINESSWIRE

    GE HealthCare to Hold an Investor Day in New York City on November 21, 2024

    BUSINESSWIRE

    GE HealthCare Showcasing SIGNA MAGNUS At AUA For Neuroscience

    BUSINESSWIRE

    GE HealthCare to Announce First Quarter 2024 Results on April 30, 2024

    BUSINESSWIRE

    It makes sense to make in India & service other markets from here: Elie Chaillot

    ECONOTICTIMES

    GE HealthCare and Hartford HealthCare Renew and Evolve 7-Year Collaboration

    BUSINESSWIRE

    GE HealthCare Establishes the GE HealthCare Foundation

    BUSINESSWIRE

    GE HealthCare and Mass General Brigham Evolve Their AI Collaboration

    BUSINESSWIRE

    GE HealthCare Technologies Commences Secondary Offering of 13,000,000 Shares

    BUSINESSWIRE

    GE HealthCare Prices Upsized Secondary Offering of 14,000,000 Shares

    BUSINESSWIRE

    GE HealthCare Technologies Inc. Prices Secondary Offering of 13,000,000 Shares

    BUSINESSWIRE

    GE HealthCare Technologies Commences Secondary Offering of 13,000,000 Shares

    BUSINESSWIRE

    GE HealthCare to Announce Fourth Quarter and Full Year 2023 Results

    BUSINESSWIRE

    GE HealthCare Management to Present at Annual J.P. Morgan Healthcare Conference

    BUSINESSWIRE

    GE HealthCare Announces Cash Dividend for Fourth Quarter of 2023

    BUSINESSWIRE

    iCAD`s AI-powered solutions to Help Accelerate Breast Cancer Detection

    GLOBENEWSWIRE

    GE HealthCare Showcases More Than 40 Innovations

    BUSINESSWIRE

    Madison and GE HealthCare Broaden Shared Commitment to Innovation

    BUSINESSWIRE

    GE HealthCare to Hold Fireside Chat with Citi Medtech Analyst at RSNA 2023

    BUSINESSWIRE

    GE HealthCare and Masimo Collaborate to Bring Masimo SET Pulse Oximetry

    BUSINESSWIRE

    GE HealthCare Announces New Data Validating Artificial Intelligence Models

    BUSINESSWIRE

    GE HealthCare Reports Third Quarter 2023 Financial Results

    BUSINESSWIRE

    GE HealthCare beats quarterly profit estimates on imaging device demand

    REUTERS

    GE HealthCare and reLink Medical Collaborate to Help Reduce Medical Device Waste

    BUSINESSWIRE

    GE HealthCare to Announce Third Quarter 2023 Results on October 31, 2023

    BUSINESSWIRE

    SOFIE & GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

    BUSINESSWIRE

    GE HealthCare’s growing list of medical institutions conducting human subject research studies with its novel photon counting CTi technology further expands with the addition of Stanford Medicine

    BUSINESSWIRE

    GE HealthCare and University Hospitals Enter 10-Year Strategic Collaboration

    BUSINESSWIRE

    GE HealthCare Announces Cash Dividend for Third Quarter of 2023

    BUSINESSWIRE

    GE HealthCare Shares Key Focus Areas in its Inaugural Sustainability Report

    BUSINESSWIRE

    GE HealthCare gets $44 mln grant to develop AI-assisted ultrasound tech

    REUTERS

    GE HealthCare Management to Present at September Investor Conferences

    BUSINESSWIRE

    GE HealthCare eyes imaging boom after Alzheimer’s drug gains

    FIERCE BIOTECH

    GE HealthCare Reports Second Quarter 2023 Financial Results

    BUSINESSWIRE

    GE HealthCare Announces Cash Dividend for Second Quarter of Fiscal Year 2023

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.